Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Clin Gastroenterol Hepatol ; 21(6): 1523-1532.e1, 2023 06.
Artigo em Inglês | MEDLINE | ID: mdl-35421583

RESUMO

BACKGROUND & AIMS: Noninvasive assessment of histological features of nonalcoholic fatty liver disease (NAFLD) has been an intensive research area over the last decade. Herein, we aimed to develop a simple noninvasive score using routine laboratory tests to identify, among individuals at high risk for NAFLD, those with fibrotic nonalcoholic steatohepatitis (NASH) defined as NASH, NAFLD activity score ≥4, and fibrosis stage ≥2. METHODS: The derivation cohort included 264 morbidly obese individuals undergoing intraoperative liver biopsy in Rome, Italy. The best predictive model was developed and internally validated using a bootstrapping stepwise logistic regression analysis (2000 bootstrap samples). Performance was estimated by the area under the receiver operating characteristic curve (AUROC). External validation was assessed in 3 independent European cohorts (Finland, n = 370; Italy, n = 947; England, n = 5368) of individuals at high risk for NAFLD. RESULTS: The final predictive model, designated as Fibrotic NASH Index (FNI), combined aspartate aminotransferase, high-density lipoprotein cholesterol, and hemoglobin A1c. The performance of FNI for fibrotic NASH was satisfactory in both derivation and external validation cohorts (AUROC = 0.78 and AUROC = 0.80-0.95, respectively). In the derivation cohort, rule-out and rule-in cutoffs were 0.10 for sensitivity ≥0.89 (negative predictive value, 0.93) and 0.33 for specificity ≥0.90 (positive predictive value, 0.57), respectively. In the external validation cohorts, sensitivity ranged from 0.87 to 1 (negative predictive value, 0.99-1) and specificity from 0.73 to 0.94 (positive predictive value, 0.12-0.49) for rule-out and rule-in cutoff, respectively. CONCLUSION: FNI is an accurate, simple, and affordable noninvasive score which can be used to screen for fibrotic NASH in individuals with dysmetabolism in primary health care.


Assuntos
Hepatopatia Gordurosa não Alcoólica , Obesidade Mórbida , Humanos , Hepatopatia Gordurosa não Alcoólica/diagnóstico , Hepatopatia Gordurosa não Alcoólica/patologia , Cirrose Hepática/diagnóstico , Cirrose Hepática/patologia , Fibrose , Valor Preditivo dos Testes , Biópsia , Fígado/patologia
2.
Genes (Basel) ; 14(5)2023 05 09.
Artigo em Inglês | MEDLINE | ID: mdl-37239419

RESUMO

(1) Background: Phenotype prediction is a pivotal task in genetics in order to identify how genetic factors contribute to phenotypic differences. This field has seen extensive research, with numerous methods proposed for predicting phenotypes. Nevertheless, the intricate relationship between genotypes and complex phenotypes, including common diseases, has resulted in an ongoing challenge to accurately decipher the genetic contribution. (2) Results: In this study, we propose a novel feature selection framework for phenotype prediction utilizing a genetic algorithm (FSF-GA) that effectively reduces the feature space to identify genotypes contributing to phenotype prediction. We provide a comprehensive vignette of our method and conduct extensive experiments using a widely used yeast dataset. (3) Conclusions: Our experimental results show that our proposed FSF-GA method delivers comparable phenotype prediction performance as compared to baseline methods, while providing features selected for predicting phenotypes. These selected feature sets can be used to interpret the underlying genetic architecture that contributes to phenotypic variation.


Assuntos
Algoritmos , Fenótipo , Genótipo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA